IP Library Granted Patent US 12,402,900
Granted Patent B2
US 12,402,900 · App. 18/918,026 · Granted Sep 2, 2025

Blood vessel shock wave treatment catheter

Inventor: Iulian Cioanta (Milton, GA)
Assignee: SANUWAVE, INC.
A61B17/22012A61B17/22004A61B17/2202A61B17/22022A61B17/22029A61B17/225A61B18/245A61B18/26A61H9/0057A61H23/008G10K11/28A61B2017/00867A61B17/22A61B2017/22014A61B2017/22024A61B2017/22025A61B2017/22039A61B2017/22051A61B2017/22054A61B2017/22067A61B2017/22079A61B2017/22082A61B2017/22084A61B2017/2212A61B2017/2253A61B17/2255A61H2201/14A61H2201/1664A61N2007/0008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,402,900
App. No.
18/918,026
Granted
Sep 2, 2025
Kind
B2
Abstract

An apparatus includes a catheter sized to fit within a wall of a blood vessel, wherein the catheter includes a balloon with a liquid inlet coupled to the catheter, a plurality of shock wave generators coupled to the catheter within the balloon, and wherein the shock wave generators upon electrical discharge produce shock waves that propagate away from the catheter toward the wall of the blood vessel, and one or more radiopaque markers coupled to the catheter to identify the location of the balloon.

Claims (17)

1. An apparatus comprising:

a blood vessel catheter including a distal end insertable into a blood vessel and a proximal end opposite the distal end;

a first electrode paired with a second electrode within a non-perforated balloon coupled to and inflatable around the catheter between the distal end and the proximal end, wherein the distal end of the catheter extends beyond a sealed end of the balloon, and wherein the balloon includes a liquid inlet;

the first electrode and second electrode aligned to not extend beyond the distal end of the catheter; and

a first radiopaque marker coupled to the catheter that visually indicates a first end of the balloon nearer the proximal end of the catheter and a second radiopaque marker coupled to the catheter that visually indicates a second distal end of the catheter nearer the distal end of the catheter; and

the first and second electrodes positioned within the balloon between the first and second radiopaque markers.

2. The apparatus of claim 1 , further comprising an electronic controller connection to at least one of the first and second electrodes.

3. A method of treating a target area of a blood vessel wall with the apparatus of claim 1 , further comprising providing liquid into the balloon after aligning the catheter and first electrode and second electrode at a desired position relative to the target area with guidance by the first radiopaque marker and the second radiopaque marker and removing liquid from the balloon after delivering shock wave treatment.

4. The apparatus of claim 1 , wherein the first electrode and second electrode are configured to produce non-focused shock waves.

5. An apparatus comprising:

a catheter sized to fit within a blood vessel, wherein the catheter includes a distal end that is insertable into a blood vessel and a proximal end opposite the distal end;

a non-perforated balloon coupled to and inflatable around the catheter between the distal end and the proximal end, wherein the distal end of the catheter extends beyond a sealed end of the balloon;

a liquid inlet in the balloon;

a plurality of shock wave generators coupled to the catheter within the balloon, wherein the shock wave generators upon electrical discharge produce shock waves that propagate away from the length of the catheter;

one or more radiopaque markers coupled to the catheter to identify the location of the balloon; and

an electronic controller connection to the shock wave generators, wherein the plurality of shock wave generators is configured to produce non-focused shock waves.

6. The apparatus of claim 2 , wherein the first electrode and second electrode are configured to produce non-focused shock waves.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2025
From: SANUWAVE, INC.
To: VASCULAR WAVE LLC
Reel/Frame 072125/0296 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2025
From: CIOANTA, IULIAN
To: SANUWAVE, INC.
Reel/Frame 070289/0753 →
Continuity (9)
Continuation 18656345 · May 6, 2024
Continuation 17937446 · Oct 1, 2022
Division 16860544 · Apr 28, 2020
Division 14874650 · Oct 5, 2015
Continuation 14272155 · May 7, 2014
Division 14036461 · Sep 25, 2013
Division 12832932 · Jul 8, 2010
Provisional Application 61223919 · Jul 8, 2009
Related Publication 20250032135A1 · Jan 30, 2025
References Cited (124)
US 4528853A · Lerch et al. · 1985 [cited by applicant]
US 4608983A · Mueller et al. · 1986 [cited by applicant]
US 4639904A · Riedlinger · 1987 [cited by applicant]
US 4696299A · Shene et al. · 1987 [cited by applicant]
US 4730614A · Lacruche et al. · 1988 [cited by applicant]
US 4836191A · Noske et al. · 1989 [cited by applicant]
US 4866330A · Lacruche et al. · 1989 [cited by applicant]
US 4868791A · Cathignol et al. · 1989 [cited by applicant]
US 4901709A · Rattner · 1990 [cited by applicant]
US 4905672A · Schwarze et al. · 1990 [cited by applicant]
US 4940050A · Forssmann et al. · 1990 [cited by applicant]
US 5152768A · Bhatta · 1992 [cited by applicant]
US 5209221A · Riedlinger · 1993 [cited by applicant]
US 5256141A · Gencheff et al. · 1993 [cited by applicant]
US 5269291A · Carter · 1993 [cited by applicant]
US 5301659A · Brisson et al. · 1994 [cited by applicant]
US 5318014A · Carter · 1994 [cited by applicant]
US 5362309A · Carter · 1994 [cited by applicant]
US 5408363A · Kano · 1995 [cited by applicant]
US 5451220A · Ciervo · 1995 [cited by applicant]
US 5474531A · Carter · 1995 [cited by applicant]
US 5509896A · Carter · 1996 [cited by applicant]
US 5524620A · Rosenschein · 1996 [cited by applicant]
US 5577506A · Dias · 1996 [cited by applicant]
US 5609606A · O'Boyle · 1997 [cited by applicant]
US 5665053A · Jacobs · 1997 [cited by applicant]
US 5676655A · Howard et al. · 1997 [cited by applicant]
US 5681336A · Clement et al. · 1997 [cited by applicant]
US 5709676A · Alt · 1998 [cited by applicant]
US 5788496A · Marlinghaus · 1998 [cited by applicant]
US 6036661A · Schwartz et al. · 2000 [cited by applicant]
US 6073051A · Sharkey et al. · 2000 [cited by applicant]
US 6113570A · Siegel et al. · 2000 [cited by applicant]
US 6126619A · Peterson et al. · 2000 [cited by applicant]
US 6186963B1 · Schwarze et al. · 2001 [cited by applicant]
US 6217531B1 · Reitmajer · 2001 [cited by applicant]
US 6241692B1 · Tu et al. · 2001 [cited by applicant]
US 6298264B1 · Zhong et al. · 2001 [cited by applicant]
US 6361531B1 · Hissong · 2002 [cited by applicant]
US 6395016B1 · Oron et al. · 2002 [cited by applicant]
US 6464660B2 · Brisken et al. · 2002 [cited by applicant]
US 6475210B1 · Phelps et al. · 2002 [cited by applicant]
US 6478765B2 · Siegel et al. · 2002 [cited by applicant]
US 6500134B1 · Cassone · 2002 [cited by applicant]
US 6629534B1 · St. Goar et al. · 2003 [cited by applicant]
US 6755821B1 · Fry · 2004 [cited by applicant]
US 7128719B2 · Rosenberg · 2006 [cited by applicant]
US 7189209B1 · Ogden et al. · 2007 [cited by applicant]
US 7311678B2 · Spector · 2007 [cited by applicant]
US 7850685B2 · Kunis et al. · 2010 [cited by applicant]
US 8040756B2 · Wang et al. · 2011 [cited by applicant]
US 20010023326A1 · Spector · 2001 [cited by applicant]
US 20020002345A1 · Marlinghaus · 2002 [cited by applicant]
US 20020032394A1 · Brisken et al. · 2002 [cited by applicant]
US 20020072691A1 · Thompson · 2002 [cited by applicant]
US 20020095147A1 · Shadduck · 2002 [cited by applicant]
US 20020095169A1 · Maitoland et al. · 2002 [cited by applicant]
US 20020111618A1 · Stewart et al. · 2002 [cited by applicant]
US 20020133099A1 · Ein-Gal · 2002 [cited by applicant]
US 20020151825A1 · Rubenchick et al. · 2002 [cited by applicant]
US 20020177889A1 · Brisken et al. · 2002 [cited by applicant]
US 20020188243A1 · Brisken et al. · 2002 [cited by applicant]
US 20030181833A1 · Faragalla et al. · 2003 [cited by applicant]
US 20030225346A1 · Ein-Gal · 2003 [cited by applicant]
US 20040006288A1 · Spector et al. · 2004 [cited by applicant]
US 20040010211A1 · Spector · 2004 [cited by applicant]
US 20050027198A1 · Couvillon · 2005 [cited by applicant]
US 20050075588A1 · Simnacher et al. · 2005 [cited by applicant]
US 20050228370A1 · Sterzer et al. · 2005 [cited by applicant]
US 20060100550A1 · Schultheiss et al. · 2006 [cited by applicant]
US 20060190022A1 · Beyar · 2006 [cited by examiner]
US 20060241523A1 · Sinelnikov et al. · 2006 [cited by applicant]
US 20060246044A1 · Lutz et al. · 2006 [cited by applicant]
US 20060265000A1 · Azizi · 2006 [cited by applicant]
US 20060293708A1 · Voss · 2006 [cited by applicant]
US 20070016112A1 · Schultheiss et al. · 2007 [cited by applicant]
US 20070055154A1 · Torbati · 2007 [cited by applicant]
US 20070055156A1 · Desilets et al. · 2007 [cited by applicant]
US 20070065420A1 · Johnson · 2007 [cited by applicant]
US 20070239083A1 · Voss · 2007 [cited by applicant]
US 20080009885A1 · Del Giglio · 2008 [cited by applicant]
US 20080071198A1 · Ogden · 2008 [cited by applicant]
US 20080269651A1 · Warlick et al. · 2008 [cited by applicant]
US 20080275371A1 · Hoffmann · 2008 [cited by applicant]
US 20080294127A1 · Blott et al. · 2008 [cited by applicant]
US 20090036803A1 · Warlick et al. · 2009 [cited by applicant]
US 20090105738A1 · Apperson et al. · 2009 [cited by applicant]
US 20090281464A1 · Cioanta et al. · 2009 [cited by applicant]
US 20090312768A1 · Hawkins et al. · 2009 [cited by applicant]
US 20100036294A1 · Mantell et al. · 2010 [cited by applicant]
US 20100114020A1 · Hawkins et al. · 2010 [cited by applicant]
US 20100114065A1 · Hawkins et al. · 2010 [cited by applicant]
US 20100228192A1 · O'Dea et al. · 2010 [cited by applicant]
US 20110028868A1 · Spector · 2011 [cited by applicant]
US 20130030447A1 · Adams · 2013 [cited by applicant]
US 20130345600A1 · Katragadda · 2013 [cited by applicant]
EP 0238772 · 1987 [cited by applicant]
FR 2673542 · 1992 [cited by applicant]
JP 2004215862 · 2004 [cited by applicant]
WO 9210140 · 1992 [cited by applicant]
WO 9406355 · 1994 [cited by applicant]
WO 9913943 · 1999 [cited by applicant]
WO 9933391 · 1999 [cited by applicant]
WO 0207582 · 2002 [cited by applicant]
WO 2006114783 · 2006 [cited by applicant]
WO 2009152352A2 · 2009 [cited by applicant]
Christ, C., et al., “Boosting skin elasticity and revitalising the dermis in cellulite and connective tissue weakness by means of extracorporeal Acoustic Wave Therapy (AWT),” http://www.cellulite-therapy.com, Jan. 2008,… [cited by applicant]
Kuhn, et al., “Impace of extracorporeal shock waves on the human skin with cellulite: A case study of an unique instance,” Clinical Interventions in Aging, 2008, pp. 201-210, vol. 3, Issuse 1, Dove Medical Press Ltd., U… [cited by applicant]
Angehrn, et al., Can cellulite be treated with low-energy extracorporeal shock wave therapy?, Clinical Interventions in Aging, 2007, pp. 623-630, vol. 2, Issue 4, Dove Medical Press Ltd., United Kingdom. [cited by applicant]
“Laser Atherectomy in Peripheral Arterial Disease: Cath Lab Digest talks with Rajesh M. Dave, MD, FACC, FSCAI, Chairman, Endovascular Medicine, Pinnacle Health Heart and Vascular Institute Harrisburg Hospital, Harrisbur… [cited by applicant]
Hoye, et al., “Successful Use of a New Guidewire with Radiofrequency Ablation Capability for the Treatment of Chronic Total Occlusion at the Ostium of the Left Anterior Descending Artery,” Cath Lab Digest, Jun. 2005, pp… [cited by applicant]
Vorwerk, et al., “Chronic venous occlusions in haemodialysis shunts: efficacy of percutaneous treatment,” Nephrology Dialysis Transplantation, 1995, pp. 1869-1873, vol. 10, No. 10, European Renal Association- European D… [cited by applicant]
ESWT (Extracorporeal Shock Wave Therapy) in comparison to UDWT (Unfocused Pressure Wave Therapy), http://www.wolfendoskopi.com. [cited by applicant]
Lau, M.D., et al., “Vulnerable Plaques: A Brief Review of the Concept and Proposed Approaches to Diagnosis and Treatment,” Technology Assessment Prepared for the Agency for Healthcare Research and Quality of the U.S. De… [cited by applicant]
Hongbao, et al., “Laser Stabilization of the Vulnerable Plaque to Prevent Heart Attacks,” The Journal of American Science, Mar. 2007, pp. 18-27, vol. 3, No. 1, Marsland Press, Lansing, MI. [cited by applicant]
Ong Lim, M.D., et al., “Vulnerable Plaque,” SIS Almanac Online (http://www.sis.org/almanac/vul_plaq.pdf), 2002, Science Innovation Synergy, Seattle, WA. [cited by applicant]
Cassak, “Vulnerable Plaque Heats Up,” In Vivo: The Business & Medicine Report, Oct. 2002, p. 23, Windhover Information, Inc. Norwalk, CT. [cited by applicant]
“Vulnerable Plaque,” http://texasheart.org/HIC/Topics/Cond/vulplaq.cfm#, Texas Heart Institute, Houston, TX. [cited by applicant]
European Patent Office Communication from EP 10 797 881.9-1659; Jan. 20, 2015. [cited by applicant]
Extended European Search Report from EP 16186021.8-1659; Nov. 21, 2016. [cited by applicant]
Goldenstedt, C. et al. (2008) Delivery by shock waves of active principle embedded in gelatin-based capsules. Ultrasonics Sonochemistry. 15(5): 808-814. [cited by applicant]
Watson, J. et al. (1999) Physiological Effects of Endermologie®: A Preliminary Report. Aesthetic Surgery Journal. 19 (1): 27-33. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/061,278, issued Mar. 3, 2023 (29 Pages). [cited by applicant]
Judgement, Final Written Decision issued on Jul. 20, 2020, in IPPR2019-00408, 62 pgs. [cited by applicant]